Conradi–Hünermann syndrome

From WikiMD's WELLNESSPEDIA

(Redirected from Happle syndrome)


Conradi–Hünermann syndrome
Synonyms Conradi–Hünermann–Happle syndrome, X-linked dominant chondrodysplasia punctata
Pronounce N/A
Specialty N/A
Symptoms Skeletal dysplasia, cataracts, ichthyosis
Complications N/A
Onset Congenital
Duration Lifelong
Types N/A
Causes Genetic mutation in the EBP gene
Risks Female carriers, X-linked dominant inheritance
Diagnosis Clinical evaluation, genetic testing
Differential diagnosis Chondrodysplasia punctata, Rhizomelic chondrodysplasia punctata
Prevention N/A
Treatment Symptomatic treatment, surgical intervention
Medication N/A
Prognosis Variable, depending on severity
Frequency Rare
Deaths N/A


Conradi–Hünermann syndrome (also known as Happle syndrome) is a rare, genetic disorder characterized by skeletal malformations, skin abnormalities, cataracts and short stature. It is a form of chondrodysplasia punctata, a group of disorders characterized by the formation of punctate calcifications in growing cartilage.

Symptoms and Signs[edit]

The symptoms of Conradi-Hünermann syndrome can vary greatly from person to person. Some common symptoms include:

Causes[edit]

Conradi-Hünermann syndrome is caused by mutations in the EMD2 gene. This gene provides instructions for making a protein that is essential for the normal development of skin, bones, and eyes. Mutations in the EMD2 gene disrupt this normal development, leading to the symptoms of Conradi-Hünermann syndrome.

Diagnosis[edit]

Diagnosis of Conradi-Hünermann syndrome is based on the presence of characteristic symptoms and signs. Genetic testing can confirm the diagnosis by identifying a mutation in the EMD2 gene.

Treatment[edit]

There is no cure for Conradi-Hünermann syndrome. Treatment is supportive and based on the symptoms present in each individual. This may include physical therapy for skeletal malformations, surgery for cataracts, and skin care for ichthyosis.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.